Cow's Milk Allergy in Babies and Children: A Parent's Complete Guide

Cow's milk protein allergy (CMPA) affects 2–3% of infants in the first year of life, making it the most common food allergy in early childhood. Unlike lactose intolerance, which is a digestive enzyme deficiency, CMPA is a genuine immune response to one or more proteins in cow's milk, primarily casein and whey proteins. The condition presents in two distinct ways with different timelines, symptoms, and diagnostic approaches, and understanding which type your child has is the starting point for managing it correctly. The good news, often underemphasised in the anxious early weeks of diagnosis, is that the prognosis is excellent: the vast majority of children with CMPA outgrow it entirely before school age.

IgE-Mediated vs Non-IgE-Mediated CMPA: Why the Distinction Matters

CMPA divides into two immunological subtypes with fundamentally different characteristics. Getting the distinction right shapes everything that follows: which tests will work, how long reactions take to appear, and which treatment protocol applies.

IgE-Mediated (Immediate) CMPA

In IgE-mediated allergy, the immune system produces immunoglobulin E antibodies specific to milk proteins. On re-exposure to milk, these antibodies trigger mast cells to release histamine and other inflammatory mediators, causing rapid symptoms. The timeline is characteristic: reactions occur within minutes to 2 hours of milk exposure. Symptoms include hives or urticaria (red, itchy raised welts on the skin), lip and face swelling (angioedema), vomiting, wheezing, and in severe cases, anaphylaxis with cardiovascular and respiratory involvement.

IgE-mediated CMPA can be confirmed with an objective test: a skin prick test (SPT) with milk extract, or a specific IgE blood test (formerly called RAST, now typically run as ImmunoCAP by Thermo Fisher Scientific). A positive result above a defined threshold confirms sensitisation. However, a positive test result does not always mean clinical allergy: sensitisation and clinical reactivity are not the same, and an allergist's interpretation of results in clinical context is essential.

Non-IgE-Mediated (Delayed) CMPA

Non-IgE-mediated CMPA is more common than the IgE-mediated type and more frequently missed, precisely because the delay between exposure and symptoms makes the connection less obvious. Symptoms appear 2–72 hours after milk ingestion. They include persistent eczema (particularly if it begins in the first weeks of life and does not respond to standard moisturising and steroid treatment), reflux that is unusually severe or unresponsive to standard treatment, loose or watery stools, blood or mucus in the nappy, and faltering growth.

Critically, no reliable blood test or skin test exists for non-IgE-mediated CMPA. Skin prick tests and specific IgE blood tests are negative in this condition because the mechanism does not involve IgE antibodies. Diagnosis relies on a supervised elimination diet trial: dairy is removed from the infant's diet (and from the breastfeeding mother's diet if the baby is breastfed) for 2–4 weeks, followed by reintroduction to see if symptoms return. This process should be conducted under the supervision of a paediatric dietitian.

Formula Options for Formula-Fed Infants

For formula-fed infants with confirmed or suspected CMPA, standard cow's milk-based formula must be replaced. The choice of alternative formula depends on the severity and type of allergy.

Extensively Hydrolysed Formula (eHF): First Line

Extensively hydrolysed formula is the first-line recommendation for most infants with CMPA. In eHF, cow's milk proteins are broken down (hydrolysed) into very small peptides that the immune system is far less likely to recognise as allergens. UK brands available on NHS prescription include Aptamil Pepti 1 and 2 (Danone), Nutramigen LGG 1 and 2 (Mead Johnson/Reckitt), and Similac Alimentum (Abbott). Approximately 90% of infants with CMPA tolerate eHF without reaction.

Note that "partially hydrolysed" or "comfort" formulas (marketed for colic and general digestive comfort in non-allergic babies) are not appropriate for CMPA. The protein fragments in partially hydrolysed formulas remain large enough to trigger allergic responses.

Amino Acid Formula (AAF): For Severe Cases

The 10% of CMPA infants who do not tolerate eHF require amino acid formula (AAF), in which protein is provided not as peptides but as individual free amino acids. This is the most hypoallergenic formula available: there are no intact peptide chains for the immune system to react to. UK brands include Neocate LCP (Nutricia), Nutramigen Puramino (Reckitt), and Alfamino (Nestlé). AAF is also first-line for infants with multiple food protein allergies or eosinophilic gastrointestinal disorders. All are available on NHS prescription in the UK with a GP or paediatric allergy team diagnosis.

Soy formula is a common question: while it seems like a logical dairy-free alternative, 15–35% of infants with CMPA also react to soy protein. Current UK and European allergy guidelines (BSACI 2019 update) do not recommend soy formula as first-line for CMPA in infants under 6 months, and it should only be used after specialist assessment.

Breastfeeding with CMPA

Breastfeeding mothers can continue to breastfeed an infant with CMPA, but they must eliminate all dairy from their own diet. Cow's milk proteins, particularly beta-lactoglobulin and casein, pass into breast milk at low but immunologically relevant concentrations in some mothers. Eliminating dairy from the maternal diet typically resolves symptoms in the breastfed infant within 2–4 weeks.

A dairy elimination diet is nutritionally significant for the breastfeeding mother. Daily calcium intake should be maintained at 1,250mg via non-dairy sources (calcium-fortified plant milks, canned sardines with bones, broccoli, fortified bread, calcium supplements). A registered dietitian referral, available via the GP or health visitor, is important to ensure nutritional adequacy during extended dairy elimination.

The Milk Ladder: Structured Reintroduction

The milk ladder is a structured, step-by-step reintroduction protocol developed by UK paediatric allergy dietitians (originally published by the iMAP team, now incorporated into the BSACI and MAP guidelines). Its central insight is that cow's milk proteins become progressively less allergenic as they are heated and incorporated into food matrices. Baked milk (in a biscuit or cake baked at 180°C for 30 minutes) is tolerated by roughly 70–75% of children with non-IgE-mediated CMPA, even those who cannot tolerate plain milk.

The standard milk ladder has 12 steps, progressing from least to most allergenic milk forms:

1. Milk biscuits (e.g., a Rich Tea biscuit, which contains a small amount of dried milk)
2. Baked goods with larger quantities of well-baked milk (muffin, pancake)
3. Pasta cooked in milk
4. Cheese sauce (cooked hard cheese)
5. Soft cooked cheese (like ricotta in a lasagne)
6. Cheese pizza
7. Yogurt (heated)
8. Yogurt (unheated)
9. Soft fresh cheese (cream cheese, fromage frais)
10. Pasteurised soft cheese
11. Regular cow's milk in cooking
12. Cow's milk as a drink

Each rung is maintained for approximately 1 week if tolerated, with the family moving up only if no reaction occurs. If a reaction occurs at any step, that step is maintained for a further 4–8 weeks before reattempting. The milk ladder is for non-IgE-mediated and mild IgE-mediated CMPA; children with a history of severe IgE-mediated reactions or anaphylaxis require allergist-supervised challenges rather than home reintroduction.

Prognosis: Most Children Outgrow CMPA

The natural history of CMPA is reassuring. Based on multiple longitudinal studies:

• Approximately 50% of children with CMPA are tolerant of cow's milk by 12 months of age.
• 75% are tolerant by age 3.
• 90% are tolerant by age 6.

Resolution is more likely in children with non-IgE-mediated CMPA than in those with high IgE-mediated sensitisation. Children who tolerate baked milk earlier in the milk ladder process tend to develop full milk tolerance faster. Persistent CMPA beyond age 6 is uncommon but does occur, and those children are more likely to have concurrent allergies to other foods (egg, wheat, soy) that may persist longer.

Cross-Reactivity with Other Animal Milks

Parents frequently ask whether their child can drink goat's, sheep's, or buffalo milk. The answer for most CMPA children is no. The casein proteins responsible for most CMPA reactions are structurally similar across ruminant species. The cross-reactivity rate between cow's milk and goat's milk allergy is estimated at 90% or higher. Buffalo milk and sheep's milk carry similar cross-reactivity risks. These milks are not appropriate substitutes and should not be used without allergist confirmation that the child tolerates them.

Mare's milk and donkey milk have significantly different protein profiles from ruminant milks, with much lower casein content and different whey protein structures. Some CMPA children tolerate them, but they are not commercially available in infant formula form and should not be used as a formula replacement without medical supervision.

When to See an Allergist vs Your GP

Your GP is the appropriate first contact for suspected CMPA. In the UK, GPs can prescribe eHF without a specialist referral and can arrange skin prick testing and specific IgE blood tests for suspected IgE-mediated CMPA. A referral to a paediatric allergist is appropriate when: the child has experienced anaphylaxis or a severe IgE-mediated reaction; standard eHF is not tolerated; multiple food allergies are suspected; symptoms persist despite dietary management; or the milk ladder is not progressing as expected. In the UK, referral to a paediatric allergy clinic is available via the NHS; waiting times vary by region, typically 4–12 weeks for a non-urgent referral.

Related: Dairy-Free Baby Formula: What Parents Need to Know | Lactose Intolerance vs Milk Allergy: Key Differences